This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Rare circulating lymphoid malignancy
C3_CIRCULATING_LYMPHOID
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 1 out of 7 registries used, show all original rules. |
341 |
4. Check minimum number of eventsNone |
341 |
5. Include endpointsNone |
341 |
6. Filter based on genotype QC (FinnGen only) |
207 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Rare circulating lymphoid malignancy
based on the number of shared cases.
Similar with more cases:
- Rare circulating lymphoid malignancy, including Hilmo
- Primary_lymphoid and hematopoietic malignant neoplasms
- Liquid cancers
- Liquid cancers, including Hilmo
- Any death
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 207 | 58 | 149 |
| Unadjusted period prevalence (%) | 0.05 | 0.02 | 0.07 |
| Median age at first event (years) | 75.93 | 74.32 | 76.56 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 216
- Matched controls
- 2160
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9853.4
230.2
179
*
XW000
NOMESCO Finland
Bone marrow biopsy
65.7
163.3
96
26
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
150.1
126
*
WW500
NOMESCO Finland
Blood transfusion
40.9
99.7
64
22
Z51.5
ICD-10 Finland
Palliative care
20.0
90.7
82
64
A04AA01
ATC
ondansetron; systemic, rectal
34.8
82.3
55
21
L03AA02
ATC
filgrastim; parenteral
+∞
77.9
70
*
M04AA01
ATC
allopurinol; systemic
11.8
76.9
132
254
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
19.4
75.9
67
49
JN4BD
NOMESCO Finland
Extensive body CT
16.9
63.3
59
47
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
60.3
55
*
H02AB02
ATC
dexamethasone; systemic
165.0
59.3
60
5
A03FA01
ATC
metoclopramide; systemic, rectal
10.4
59.1
84
124
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
55.7
51
*
L03AA13
ATC
pegfilgrastim; parenteral
658.2
54.0
51
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
52.2
48
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
50.0
46
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.6
44.6
85
170
JN4AD
NOMESCO Finland
Body CT examination
10.1
41.6
54
69
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
39.8
37
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
410.2
36.1
35
*
R50.9
ICD-10 Finland
Fever, unspecified
6.2
35.0
80
187
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
33.2
31
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
186.7
31.6
32
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
31.0
29
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
31.0
29
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
31.0
29
*
N02AA05
ATC
oxycodone; systemic
5.2
29.4
83
230
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
320.8
28.5
28
*
H02AB06
ATC
prednisolone; systemic
5.1
28.3
155
714
390
Kela drug reimbursment
Ibrutinib
+∞
27.7
26
*
XX3DW
NOMESCO Finland
Time consuming IT work
9.3
26.8
35
44
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
26.6
25
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
23.7
25.3
36
18
ZX120
NOMESCO Finland
Intravenous
7.1
24.9
42
71
L01AA02
ATC
chlorambucil; oral
+∞
24.4
23
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
24.4
23
*
L01BB02
ATC
mercaptopurine; oral
70.2
22.4
25
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
22.3
21
*
212
Kela drug reimbursment
Gout
9.8
22.0
27
31
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
21.2
20
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
85.5
21.1
23
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
20.1
19
*
C90.1
ICD-10 Finland
Plasma cell leukaemia
+∞
20.1
19
*
1XC02, ,
NOMESCO Finland
219.3
19.9
20
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.9
19.7
83
300
J01MA12
ATC
levofloxacin; systemic
3.9
19.1
78
275
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
19.0
18
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
19.0
18
*
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
19.0
18
*
1512
Kela drug reimbursment
Ibrutinib
+∞
19.0
18
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
18.4
18.9
29
18
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
48.7
18.6
22
5
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.0
17
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.4
17.9
32
57
ZX112
NOMESCO Finland
Subcutaneous
46.3
17.6
21
5
TAB00
NOMESCO Finland
Lumbar puncture
8.3
17.3
24
32
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
16.9
16
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
16.9
16
*
JN6AD
NOMESCO Finland
CT of torso and neck
36.5
16.0
20
6
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
15.8
15
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
91.9
15.8
17
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
171.9
15.7
16
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
171.9
15.7
16
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
41.4
15.7
19
5
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
15.7
14.9
24
17
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
17.0
14.8
23
15
L01XE27
ATC
[U] ibrutinib
+∞
14.7
14
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
14.7
14
*
J05AB11
ATC
valaciclovir; oral
3.9
14.5
50
154
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
13.7
13
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
13.7
13
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
149.0
13.6
14
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.2
13.0
29
63
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
12.1
12.9
23
21
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
12.6
12
*
C84.1
ICD-10 Finland
Sézary disease
+∞
12.6
12
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
12.4
45
143
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.9
12.3
29
66
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
10.6
12.1
23
24
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.4
12.0
21
36
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
11.6
11
*
116
Kela drug reimbursment
Prostate cancer
+∞
11.6
11
*
L01EL01
ATC
ibrutinib; oral
+∞
11.6
11
*
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
126.5
11.5
12
*
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
126.5
11.5
12
*
127
Kela drug reimbursment
Transplant complication
37.2
11.4
14
*
WW200, ,
SPAT
0.2
10.9
8
434
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
10.5
10
*
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
10.5
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
10.5
10
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
+∞
10.5
10
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
C91.4
ICD-10 Finland
Hairy-cell leukaemia
+∞
10.5
10
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.1
10.5
*
302
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
34.4
10.5
13
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
34.4
10.5
13
*
J05AB01
ATC
aciclovir; systemic
2.9
10.4
60
251
H02AB09
ATC
hydrocortisone; systemic
12.2
10.3
18
16
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
9.9
10.3
20
22
WZC30
NOMESCO Finland
Teaching
3.4
10.0
41
140
WW409
NOMESCO Finland
Other aferesis
+∞
9.4
9
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
9.4
9
*
153
Kela drug reimbursment
Lenalidomid
+∞
9.4
9
*
9940/3-C42.1
ICD-O-3
Hairy cell leukemia, NOS, of bone marrow
+∞
9.4
9
*
B01AB10
ATC
tinzaparin; parenteral
4.1
9.1
26
69
J01MA14
ATC
moxifloxacin; systemic
3.6
9.0
32
99
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.2
9.0
19
39
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
25.3
9.0
12
5
ZX108
NOMESCO Finland
Inhalation
25.3
9.0
12
5
TGC00
NOMESCO Finland
Bronchial lavation
7.8
9.0
20
28
TPX10
NOMESCO Finland
Implantation of vascular injection port
11.4
9.0
16
15
TPH04
NOMESCO Finland
Cathetrisation of vein
2.7
8.9
62
284
A41.8
ICD-10 Finland
Other specified sepsis
10.7
8.7
16
16
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
17.2
8.7
13
8
WF002
NOMESCO Finland
Radical radiotherapy
93.6
8.5
9
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
8.4
8
*
9837/3-C42.1
ICD-O-3
Precursor T-cell lymphoblastic leukemia of bone marrow
+∞
8.4
8
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
8.4
8
*
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
+∞
8.4
8
*
ZXC50
NOMESCO Finland
Cryotherapy
9.5
8.2
16
18
L04AD01
ATC
ciclosporin; systemic
18.0
8.2
12
7
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.7
8.0
27
81
A98
ICPC
Health maint/preventive medicine
0.4
7.8
122
1613
A05AA02
ATC
ursodeoxycholic acid; oral
15.8
7.8
12
8
J02AC03
ATC
voriconazole; systemic
46.7
7.8
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
7.6
93
544
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
82.8
7.5
8
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.2
7.3
20
51
9733/3-C42.1
ICD-O-3
Plasma cell leukemia of bone marrow
+∞
7.3
7
*
1AA09, ,
NOMESCO Finland
+∞
7.3
7
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
+∞
7.3
7
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
7.3
7
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
7.3
7
*
H02AB07
ATC
prednisone; oral
2.7
7.3
43
180
UJF32
NOMESCO Finland
Coloscopy
2.4
7.1
62
313
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.2
7.1
7
322
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
6.7
26
85
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.0
6.7
32
119
GD1AD
NOMESCO Finland
Thorax CT examination
3.9
6.6
20
55
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
71.9
6.5
7
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.6
6.4
43
191
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
+∞
6.3
6
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
6.3
6
*
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
WW402
NOMESCO Finland
Leucoferesis
+∞
6.3
6
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
+∞
6.3
6
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
6.3
6
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
6.3
6
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
6.3
6
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
27.6
6.3
8
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.0
114
769
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
33
27
14.25
34.05
3.2
1.1
—
—
—
0
0
40
46
10.44
33.00
3.2
1.2
—
—
—
0
0
40
48
10.00
31.94
3.0
1.2
—
—
—
0
0
33
39
9.81
26.49
1.7
1.6
—
—
—
0
0
30
8
43.20
24.67
2.3
1.4
—
—
—
0
0
27
35
8.67
20.01
1.8
1.1
—
—
—
0
0
28
40
7.89
19.14
1.9
1.1
—
—
—
0
0
21
5
46.28
17.63
2.5
3.2
11.68
—
iu/ml
—
5
0
24
13
20.58
16.43
1.4
1.2
—
—
—
0
0
83
339
3.35
15.77
3.6
1.9
—
—
—
0
0
24
36
7.38
15.65
2.0
1.2
—
—
—
0
0
46
132
4.16
14.72
2.4
1.5
—
—
—
0
0
24
20
13.34
13.98
1.3
1.5
—
—
—
0
0
18
9
21.67
12.69
1.6
1.2
—
—
—
0
0
17
8
22.91
12.21
4.4
1.1
—
—
—
0
0
22
21
11.52
12.08
1.7
1.1
—
—
—
0
0
17
9
20.34
11.79
4.4
1.1
—
—
—
0
0
100
1504
0.38
11.30
4.3
6.5
2.58
2.47
mmol/l
0.63
83
1354
21
21
10.95
11.29
1.3
1.5
150.50
233.73
u/ml
—
8
11
21
22
10.44
11.03
1.8
1.2
—
—
—
0
0
23
29
8.74
10.92
2.0
1.1
—
—
—
0
0
26
60
4.79
10.85
2.8
4.1
—
—
—
0
0
95
1449
0.39
10.72
4.1
5.5
1.26
1.42
mmol/l
1.82
80
1299
97
1463
0.39
10.56
4.6
5.6
4.33
4.31
mmol/l
0.05
84
1319
14
6
24.80
10.38
2.8
2.0
1.64
1.17
%
—
14
6
34
100
3.85
10.37
1.8
1.7
1.33
1.44
g/l
0.18
24
92
61
258
2.90
10.37
2.8
1.8
—
—
—
0
0
23
50
5.03
10.27
6.0
1.3
141.69
1.61
ratio
1.01
15
33
58
246
2.86
9.75
2.9
1.9
—
—
—
0
0
29
80
4.03
9.64
3.6
1.7
0.77
2.00
ug/l
0.73
29
62
99
1458
0.41
9.56
5.7
7.7
41.11
40.75
mmol/mol
0.15
89
1328
9
0
+∞
9.44
1.0
0.0
—
—
—
0
0
33
102
3.64
9.35
1.8
1.4
—
—
—
0
0
24
59
4.45
9.25
6.0
1.4
2320.94
51.25
mg/l
0.52
19
54
24
59
4.45
9.25
6.0
1.4
138.57
35.53
mg/l
0.41
19
54
18
21
9.24
9.00
5.9
7.4
12.56
11.39
mg/l
0.37
18
21
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
67
4.09
8.62
3.4
2.2
0.48
0.41
iu/ml
0.29
15
35
21
49
4.64
8.61
1.3
1.2
—
—
—
0
0
11
5
23.05
8.10
5.8
1.0
—
—
—
0
0
11
5
23.05
8.10
5.8
1.2
—
—
—
0
0
11
5
23.05
8.10
5.8
1.0
—
—
—
0
0
14
13
11.42
7.92
5.0
1.1
—
—
—
0
0
14
13
11.42
7.92
5.0
1.1
—
—
—
0
0
14
13
11.42
7.92
5.0
1.1
—
—
—
0
0
17
23
7.92
7.84
3.6
1.5
33.41
33.52
pg
0.03
17
23
12
8
15.78
7.81
5.5
1.1
—
—
—
0
0
12
8
15.78
7.81
5.5
1.1
—
—
—
0
0
12
8
15.78
7.81
1.2
1.0
—
—
—
0
0
12
8
15.78
7.81
5.5
1.1
—
—
—
0
0
12
8
15.78
7.81
5.5
1.1
—
—
—
0
0
20
49
4.40
7.72
7.3
2.5
89.30
85.45
%
0.35
20
49
129
858
2.25
7.71
44.3
5.7
3.23
4.44
e9/l
8.92
123
729
13
11
12.48
7.68
1.3
1.0
—
—
—
0
0
11
6
19.21
7.68
1.2
1.0
—
—
—
0
0
97
1390
0.45
7.56
4.9
4.8
1.43
1.25
mmol/l
1.77
81
1234
11
7
16.46
7.31
2.1
1.0
—
—
—
0
0
12
10
12.62
7.17
2.0
1.0
—
—
—
0
0
11
8
14.40
6.97
2.1
1.0
—
—
—
0
0
24
75
3.48
6.65
4.8
1.6
—
—
—
0
0
111
1488
0.48
6.59
6.5
5.6
6.13
6.15
mmol/l
0.04
99
1318
14
19
7.80
6.52
1.9
1.2
—
—
—
0
0
6
0
+∞
6.28
2.5
0.0
—
—
—
0
0
14
21
7.05
6.14
3.4
2.0
—
—
—
0
0
33
131
2.79
6.13
6.0
4.0
2.03
2.45
mmol/l
0.21
28
94
40
178
2.53
5.94
6.9
2.6
4.98
7.28
umol/l
2.11
32
154
22
71
3.34
5.80
2.2
1.5
—
—
—
0
0
35
150
2.59
5.60
5.8
3.9
4.91
5.18
kpa
1.22
35
142
106
1403
0.52
5.27
4.3
4.9
2.29
2.01
mu/l
1.25
96
1241
5
0
+∞
5.23
1.2
0.0
—
—
—
0
0
16
37
4.59
5.05
1.7
1.3
—
—
—
0
0
20
67
3.19
4.97
4.9
1.3
6.59
0.33
g/l
1.06
15
58
100
685
1.86
4.71
8.9
2.7
—
—
estimate
—
0
0
136
1644
0.53
4.51
77.2
25.2
3.72
4.45
e12/l
24.86
131
1584
123
908
1.82
4.46
19.9
7.2
1.21
1.21
mmol/l
0.04
103
778
7
6
12.00
4.30
1.4
1.2
—
—
—
0
0
7
6
12.00
4.30
1.4
1.2
—
—
—
0
0
63
386
1.89
4.11
9.7
2.3
—
—
—
0
0
10
22
4.71
3.47
2.1
1.3
14345.90
2052.36
e6/l
—
10
14
28
135
2.23
3.46
2.6
1.7
—
—
—
0
0
9
18
5.17
3.41
2.0
1.3
30492.22
17307.55
e6/l
—
9
11
57
361
1.79
3.28
4.8
1.8
2.77
1.37
mg/l
1.03
52
288
14
49
2.99
3.26
15.8
4.7
1.49
1.96
mg/l
1.30
14
39
26
125
2.23
3.24
11.7
3.2
1.24
1.22
mmol/l
0.69
26
100
41
657
0.54
3.23
3.3
4.2
31.05
7.32
mg/mmol
0.78
25
431
12
36
3.47
3.07
1.2
1.3
—
—
—
0
0
5
5
10.19
2.99
1.2
1.0
—
—
—
0
0
8
17
4.84
2.95
2.1
1.1
—
—
—
0
0
8
17
4.84
2.95
2.1
1.1
—
—
—
0
0
8
17
4.84
2.95
2.1
1.1
—
—
—
0
0
12
38
3.28
2.90
1.6
1.4
—
—
—
0
0
120
1437
0.63
2.80
46.8
16.7
65.97
71.88
ml/min/173m2
2.42
115
1329
8
19
4.33
2.70
2.3
1.1
—
—
—
0
0
8
19
4.33
2.70
2.3
1.1
—
—
—
0
0
8
19
4.33
2.70
2.3
1.1
—
—
—
0
0
39
234
1.81
2.66
14.6
3.6
5.42
5.87
kpa
1.96
39
226
96
1197
0.64
2.59
68.5
21.3
15.49
13.77
%
14.03
96
1174
5
7
7.28
2.56
1.4
3.1
4691.00
2528.57
u/ml
—
5
7
38
229
1.80
2.55
14.9
3.6
1.89
1.74
mmol/l
0.12
32
190
90
1135
0.65
2.54
3.9
3.7
15.19
15.07
pmol/l
0.15
81
1000
6
12
5.11
2.42
6.3
1.8
—
—
—
0
0
5
9
5.66
2.22
1.2
2.7
—
—
—
0
0
5
9
5.66
2.22
1.2
2.7
—
—
—
0
0
11
44
2.58
2.04
2.1
1.2
—
—
—
0
0
70
521
1.51
2.04
2.2
2.4
2.99
2.74
mg/l
0.44
59
438
28
441
0.58
1.95
3.5
2.9
0.68
0.85
ug/l
0.99
21
307
6
16
3.82
1.95
1.3
1.0
—
—
—
0
0
67
508
1.46
1.75
3.6
3.1
0.62
0.55
e6/l
0.12
53
382
0
47
0.00
1.73
0.0
1.8
—
3.50
—
0
37
11
223
0.47
1.72
1.5
1.2
1.25
14.09
u/ml
—
6
75
6
19
3.22
1.67
1.3
1.3
—
—
—
0
0
10
44
2.33
1.58
1.0
1.7
—
—
—
0
0
47
629
0.68
1.56
4.1
4.1
21.27
25.21
%
1.06
28
332
28
417
0.62
1.54
3.9
3.9
1.02
1.02
kg/l
0.47
18
271
70
868
0.71
1.51
2.4
2.2
91.65
94.26
pmol/l
0.17
43
448
23
141
1.71
1.49
3.3
2.0
31.29
31.61
u/l
0.03
17
112
27
177
1.60
1.37
7.4
3.4
—
—
—
0
0
25
162
1.61
1.33
2.1
1.8
352.24
370.01
nmol/l
0.16
25
142
6
24
2.54
1.31
1.2
1.3
—
—
—
0
0
51
387
1.42
1.31
1.9
1.8
949.31
1152.09
nmol/l
0.95
43
301
0
33
0.00
1.17
0.0
1.5
—
—
—
0
0
0
34
0.00
1.17
0.0
2.6
—
—
—
0
0
8
40
2.04
1.13
1.9
1.3
—
—
—
0
0
8
40
2.04
1.13
1.9
1.3
—
—
—
0
0
61
491
1.34
1.09
8.4
2.7
50.59
39.98
u/l
0.33
56
466
6
124
0.47
1.08
2.5
2.5
15.25
15.65
nmol/l
—
6
112
68
800
0.78
0.91
4.2
4.5
1.95
2.18
ug/l
0.44
60
698
82
704
1.27
0.89
3.1
2.9
601.72
146.70
ug/l
4.14
74
639
8
42
1.94
0.89
1.4
1.1
—
—
—
0
0
8
43
1.89
0.88
1.4
1.1
—
—
—
0
0
27
197
1.42
0.87
18.3
3.2
4.90
4.45
kpa
0.61
27
189
0
27
0.00
0.78
0.0
2.4
—
—
—
0
0
6
34
1.79
0.77
3.3
2.1
105.00
105.18
mmol/l
—
6
34
6
34
1.79
0.77
3.3
2.1
1.21
1.18
mmol/l
—
6
34
9
54
1.70
0.75
1.3
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
8
55
1.47
0.56
4.0
1.8
115.38
132.67
g/l
—
8
42
35
287
1.26
0.56
3.9
3.1
0.88
1.80
e6/l
1.02
21
143
26
325
0.77
0.56
1.3
1.3
0.79
1.89
u/ml
—
8
76
41
485
0.81
0.56
4.0
4.0
0.00
0.00
estimate
-0.00
21
164
79
707
1.19
0.54
3.8
3.7
1710.69
1917.53
ng/l
0.25
72
611
12
83
1.47
0.53
1.2
1.3
84.20
370.46
u/ml
1.61
12
75
8
118
0.67
0.47
1.5
1.5
—
—
—
0
0
16
121
1.35
0.45
27.7
2.6
0.76
0.62
%
1.13
16
121
16
122
1.34
0.43
27.7
2.6
1.10
1.15
%
0.15
16
122
16
123
1.32
0.42
4.6
2.2
58.50
58.15
ml/min/173m2
—
10
48
13
170
0.75
0.40
1.2
1.4
—
—
—
0
0
66
726
0.87
0.39
3.9
2.5
—
—
—
0
0
33
283
1.20
0.37
24.2
6.9
103.55
104.46
mmol/l
0.48
33
283
30
255
1.20
0.37
8.6
9.1
1.85
1.40
mmol/l
0.19
21
216
37
422
0.85
0.35
1.9
1.8
388.94
412.97
pmol/l
0.32
32
337
35
309
1.16
0.29
3.9
2.9
1.53
0.94
e6/l
0.52
21
166
62
671
0.89
0.28
4.0
3.9
0.00
0.01
estimate
0.50
25
147
18
213
0.83
0.26
7.0
8.2
—
—
—
0
0
7
94
0.74
0.23
2.3
1.3
—
—
—
0
0
88
926
0.92
0.23
5.9
3.5
78.59
53.01
u/l
0.92
82
840
5
40
1.26
0.22
1.2
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
904.99
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
83
869
0.93
0.18
4.0
4.0
0.00
0.01
estimate
0.50
29
178
83
865
0.93
0.16
4.0
3.9
0.00
0.00
estimate
-0.00
28
191
124
1206
1.07
0.15
7.1
4.5
21.69
13.51
mm/h
3.40
118
1092
7
88
0.79
0.15
1.4
2.3
425.86
895.91
ug/l
—
7
82
82
850
0.94
0.13
4.0
3.9
0.00
0.00
estimate
-0.00
28
191
14
156
0.89
0.10
1.8
2.5
0.18
0.39
e6/l
1.10
14
144
49
476
1.04
0.05
4.0
3.6
0.00
0.00
estimate
-0.00
21
144
77
785
0.97
0.05
5.2
4.5
46.18
51.75
ng/l
0.20
72
612
71
716
0.99
0.00
2.0
2.5
77.80
78.71
nmol/l
0.10
60
619
14
136
1.03
0.00
13.1
9.7
24.65
24.61
mmol/l
0.01
14
131
0
8
0.00
0.00
0.0
1.0
—
9.70
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.57
—
0
5
0
5
0.00
-0.00
0.0
9.6
—
6.04
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
101.14
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
70.20
—
0
5
0
5
0.00
-0.00
0.0
3.6
—
14.52
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
0.23
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
0.27
—
0
7
0
5
0.00
-0.00
0.0
9.4
—
10.92
—
0
5
0
6
0.00
-0.00
0.0
7.2
—
—
—
0
0
6
65
0.92
-0.00
2.0
2.3
3.95
4.27
pmol/l
—
6
57
0
6
0.00
-0.00
0.0
1.0
—
11.32
—
0
6
0
6
0.00
-0.00
0.0
1.5
—
11.83
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
57.06
—
0
9
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.06
—
0
5
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_CIRCULATING_LYMPHOID – Rare circulating lymphoid malignancy
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).